SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

73,709.69 -143.21
( -0.19%)

Global Indices

Nasdaq

52,511.77 524.74
(1.01%)

Dow Jones

7,731.20 19.47
(0.25%)

Hang Seng

64,728.80 653.38
(1.02%)

Nikkei 225

10,731.75 -32.94
(-0.31%)

Forex

USD-INR

94.90 0.12
(0.13%)

EUR-INR

106.44 -0.03
(-0.02%)

GBP-INR

126.38 0.12
(0.10%)

JPY-INR

0.60 0.00
(-0.04%)

YOU ARE HERE :
HOME
Markets
Equity
Profit and Loss

EQUITY - MARKET SCREENER

Sai Life Sciences Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

544306

INE570L01029

118.0704682

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

SAILIFE

82.33

29679.07

EPS(TTM)

Face Value()

Div & Yield %

16.97

Particulars(INCOME)	Mar 2026 ( Cr)	Mar 2025 ( Cr)	Mar 2024 ( Cr)	Mar 2023 ( Cr)	Mar 2022 ( Cr)	Mar 2021 ( Cr)
Sales Turnover	2153.23	1642.05	1418.68	1157.40	841.02	751.47
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	2153.23	1642.05	1418.68	1157.40	841.02	751.47
Other Income	49.13	37.34	29.33	27.96	28.15	27.29
Stock Adjustments	7.76	-4.13	-23.80	4.59	2.83	16.50
Total Income	2210.12	1675.26	1424.21	1189.95	872.00	795.26
EXPENDITURE :
Raw Materials	568.34	445.52	408.78	413.12	251.14	232.69
Power & Fuel Cost	64.63	48.19	49.49	43.73	31.86	27.25
Employee Cost	617.73	485.56	430.63	353.76	263.37	203.64
Other Manufacturing Expenses	130.01	95.35	84.73	90.06	78.21	50.32
Selling & Administrative Expenses	199.80	135.20	117.15	84.16	84.59	85.45
Miscellaneous Expenses	-12.93	35.76	16.06	10.29	9.79	4.44
Less : Pre-operative Expenses Capitalised	0.00	0.00	0.00	0.00	0.00	0.00
Total Expenditure	1567.57	1245.57	1106.84	995.11	718.97	603.79
Operating Profit	642.55	429.69	317.37	194.84	153.03	191.46
Interest	34.08	71.94	81.15	74.38	50.98	32.11
Gross Profit	608.47	357.75	236.22	120.46	102.05	159.35
Depreciation	152.30	126.03	107.21	87.77	79.70	71.77
Profit Before Tax	456.17	231.72	129.01	32.69	22.35	87.58
Tax	87.95	33.82	7.97	10.73	9.37	3.73
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	26.74	24.44	25.81	-2.28	-2.70	18.55
Reported Net Profit	341.48	173.46	95.23	24.24	15.68	65.30
Extraordinary Items	-6.71	-1.36	0.01	-0.38	11.31	0.00
Adjusted Net Profit	348.19	174.82	95.22	24.62	4.37	65.30
Adjustment below Net Profit	1.26	0.95	1.08	2.39	0.00	0.83
P & L Balance brought forward	768.46	594.05	497.75	478.02	461.76	394.23
Statutory Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
Appropriations	0.00	0.00	0.00	6.90	-0.58	-0.21
P & L Balance carried down	1111.21	768.46	594.05	497.75	478.02	460.57
Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Equity Dividend %	0.00	0.00	0.00	383.30	396.30	0.00
Dividend Per Share(Rs)	0.00	0.00	0.00	38.33	39.63	0.00
Earnings Per Share-Unit Curr	16.12	8.32	53.92	13.76	8.93	36.65
Earnings Per Share(Adj)-Unit Curr	16.12	8.32	53.92	13.76	8.93	36.65
Book Value-Unit Curr	118.42	104.00	572.28	517.79	507.50	486.92
Book Value(Adj)-Unit Curr	118.42	104.00	572.28	517.79	507.50	486.92

73,709.69 -143.21 ( -0.19%)

52,511.77 524.74 (1.01%)

7,731.20 19.47 (0.25%)

64,728.80 653.38 (1.02%)

10,731.75 -32.94 (-0.31%)

94.90 0.12 (0.13%)

106.44 -0.03 (-0.02%)

126.38 0.12 (0.10%)

0.60 0.00 (-0.04%)